There’s growing concern that the variants could evade our vaccines. But many infectious diseases doctors say that even if antibody levels drop in the months following vaccination, the immune system is complex enough that vaccinated people will be well protected against variants, especially when it comes to severe disease, hospitalization, and death.
This Viewpoint discusses the importance of the US Congress reauthorizing funding for the President’s Emergency Plan for AIDS Relief, a program developed in 2003 that…
U.S. National Institutes of Health guidelines currently recommend nirmatrelvir/ritonavir (Paxlovid) as first-line therapy for outpatients with COVID-19
Sexually transmitted infections (STIs) are caused by bacteria, viruses, or parasites. NIAID supports research across the spectrum from basic to clinical science to develop effective…
Background: Long-acting antiretroviral therapy (LA-ART) is novel and has been used for both virologically-suppressed (VS) and viremic patients with adherence challenges. The currently-approved LA-ART combination…
Samantha Power becomes first US official to confirm famine, while aid workers decry continuing lack of help
Despite the use of vaccines, seasonal influenza remains a risk to public health. We previously proposed the inactivated whole virus particle vaccine (WPV) as an…
Pfizer said on Tuesday its respiratory syncytial virus (RSV) vaccine Abrysvo was well tolerated and generated an immune response in higher risk adults under the…
Pandemic Preparedness Symposium: Antiviral Medicines for the Next Big Threat
We show that the Simoa and intracellular cytokine staining SARS-CoV-2 nucleocapsid assays are more sensitive than the clinical Elecsys assay. These data su
Four years after the COVID-19 lockdown in San Francisco, an interview with Dr. Monica Gandhi, author of “Endemic: A Post Pandemic Playbook.”
